<P>Foley Partner Michele Simkin and former Foley attorney Todd Spalding byline “How Will Patents Impact the Commercialization of Stem Cell Therapeutics,” appeared in the October issue of the Journal of Pharmaceutical Innovation.</P> <P><A href="http://springerlink.com/content/rtx5013k15882g00/fulltext.html" target=_blank><SPAN style="COLOR: #234c67">Read full article</SPAN></A>.</P>